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ABSTRACT: Children born small for gestational age are known to
be at increased risk for adult diseases such as hypertension, diabetes,
and coronary heart disease. Oxidative stress is a common feature of
these pathogenic conditions and can be the key link between size at
birth and increased morbidity later in life. The purpose of this study
was to analyze the parameters of lipoperoxidation and changes in
antioxidant defense system as well as assess their relationship to birth
weight. Concentrations of thiobarbituric-acid-reactive-substances
and F2-isoprostanes, total antioxidant status, and the activity of both
superoxide dismutase and glutathione peroxidase were measured in
65 children (33 boys, 32 girls; ages 8–13 y). Thiobarbituric-acid-
reactive-substances and F2-isoprostane levels were significantly ele-
vated in children born small for gestational age. Nevertheless, super-
oxide dismutase activity was significantly elevated in these children
and the levels of both glutathione peroxidase activity and total
antioxidant status were unchanged. Moreover, we found that systolic
blood pressure was positively associated with thiobarbituric-acid-
reactive-substances levels in race- and gender-adjusted models but
not in a multivariable regression model. In conclusion, the current
study revealed that there is evidence of oxidative stress in children
born small for gestational age as supported by increased lipid per-
oxidation. (Pediatr Res 62: 204–208, 2007)
It has been proposed that events occurring before birth mayinfluence the risk in the development of many diseases,
including type II diabetes, asthma, hypertension, and coronary
heart disease (1–4). The fetal programming hypothesis pro-
poses that these cardiovascular and related disorders derive
from fetal adaptations, which increase the fetus’s chance of
survival in poor nutritional environments but result in perma-
nent alterations of growth characteristics, postnatal metabo-
lism, and physiology (1,2). Therefore, size at birth demands
urgent attention not only because of the significantly increased
risk it poses for infants and young children, but also for the
risk of developing diseases in adulthood.
Multifactorial events are involved in the pathogenesis of
disorders linked to fetal programming, and the identification
of the mechanism is still a matter of discussion. It has been
established that an excessive and/or sustained increase in free
radical production associated with diminished efficacy of the
antioxidant defense systems result in oxidative stress, which
occurs in many pathologic processes and contributes signifi-
cantly to disease mechanisms (5). It is reasonable to suggest
that oxidative stress would be the key link between an adverse
prenatal environment and increased morbidity later in life. In
fact, adverse fetal growth is frequently associated with a
number of oxidative insults. Longini et al. (6) demonstrated
that elevated isoprostane concentrations could be detected in
the amniotic fluid of fetal growth restriction pregnancies. In
addition, Gupta et al. (7) demonstrated that malondialdehyde
(MDA) concentration was increased whereas the activities of
SOD, catalase, and glutathione were decreased in the cord
blood of SGA infants. Urinary 8-hydroxydeoxyguanosine, a
marker of oxidative stress, was increased in infants with very
low birth weight (8). Inder et al. (9) reported a positive
association between TBARS levels and adverse respiratory
and ophthalmologic outcomes in very-low-birth-weight in-
fants. Although evidence of an interaction between oxidative
stress and size at birth was recently reported in neonates, little
evidence of this correlation has been described in children.
To understand the long-term consequences of birth weight
on oxidative or antioxidative pathways, we assessed parame-
ters of lipoperoxidative degradation and antioxidant defenses
in 8- to 13-y-old former SGA children. First, we investigated
LPO via measurement of two biomarkers: TBARS and F2-
isoprostanes. The TBARS method measures levels of MDA, a
decomposition product of peroxidized polyunsaturated fatty
acids (10). Isoprostanes are noncyclooxygenase-derived pros-
taglandin isomers products of arachidonic acid that result from
free radical-catalyzed lipid peroxidation. Measurement of
these molecules has emerged as the most reliable method to
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assess oxidative stress status in vivo (11). In particular, F2-
isoprostane (8-Epi-PGF2 ) has been implicated as a marker of
antioxidant deficiency and oxidative stress and has the poten-
tial to assess human diseases (11). Secondly, we measured the
activity of antioxidant enzymes such as SOD and GPx. These
enzymes are the first line of defense against free radicals and
are generally referred to as primary antioxidants. We also
evaluated TAS, a measurement of the total antioxidant effect
of the defense systems in circulation. These antioxidant sys-
tems include enzymatic (generally, if not exclusively, intra-
cellular) and nonenzymatic (both intra- and extracellular).
Lipid soluble and water-soluble antioxidants are involved in
these processes. Thus, the overall antioxidant capacity may
give more relevant biologic information compared with that
obtained by measuring individual components because it con-
siders the cumulative effect of all antioxidants present in
circulation (12). Finally, we tried to find out whether there is
a correlation between parameters of LPO and UA or lipid
profiles, since these metabolic parameters could have pro-
oxidant effects, which increase the rates of LPO reactions and
hence can provide better insight into the implications of
prenatal growth in SGA children.
METHODS
A total of 113 children aged 8–13 y were recruited and evaluated between
November 2004 and July 2005. Participants were selected among 289 chil-
dren screened in an anthropometric census performed in five shantytowns by
the Nutritional Rehabilitation Center of the Federal University of Sa˜o Paulo,
Brazil. Initially, 18 shantytowns were identified within 15 km of the Federal
University of Sa˜o Paulo, which is located in the southern region of Sa˜o Paulo.
The region was then subdivided into three geographic areas and a secondary
sample of five shantytowns was randomly selected taking into account this
stratification by region. Personal and family medical histories were obtained
from a questionnaire completed during an interview with the parents or
guardians. This cohort was screened with the following characteristics: chil-
dren born at term with birth weight (BW) 2.5 kg or 3.0 kg and gestational
age between 38 and 40 wk; no family history or clinical signs of hypertension,
cardiovascular disease, diabetes, or renal or chronic illness; no vitamin
supplementation; and adequate amounts of blood or urine for evaluation of the
biomarkers of oxidative stress and antioxidant status. A total of 65 children
meeting these criteria were eligible to participate in this cross-sectional study.
During enrollment, body weight, height, serum lipids, UA, and blood pressure
levels were measured using methods whose details were described elsewhere
(8). Children were divided into two groups according to their BW: 1) the
AGA group, consisting of 27 children who had been born at term with
appropriate BW (BW 3.0 kg) and 2) the SGA group, consisting of 38
children who had been born at term with small BW for gestational age (BW
2.5 kg). Cut-off points for classification of BW were recommended by the
World Health Organization (13) and details of BW data validation have been
previously published (14). The anthropometric indicators used to assess child
nutritional status were height-for-age (HAZ), weight-for-age (WAZ), and
BMI-for-age (BMIZ). The values were compared with the standards of the
National Center for Health Statistics (NCHS, 2000) and were expressed as a
Z-score (Epi Info Software Program, Version 3.3.2, Center for Disease
Control). Hypertension was defined in accordance with the Fourth National
Task Force on High Blood Pressure in Children and Adolescents (15). The
study was approved by the Research Ethics Committee of the Federal
University of Sa˜o Paulo and informed consent was obtained from one of the
parents of children enrolled in the study.
Blood and urine collection for oxidative and antioxidant biomarkers.
Blood samples were centrifuged (1500 g, 5 min, 4°C) and the erythrocytes
were washed three times with NaCl 0.9%. Aliquots of heparin plasma and
lysate erythrocytes were stored at –80°C until assay. Urine samples (15 mL)
were collected into polyethylene bottles; they were kept refrigerated during
the collection period, after which they were immediately aliquoted and stored
at –80°C until assay.
Plasma and erythrocyte assays of antioxidant enzymes. Plasma TAS was
measured using the Calbiochem total antioxidant status assay kit (Novabio-
chem, San Diego, CA) according to the manufacturer’s instructions. The
assay relies on the ability of antioxidants in the sample to inhibit the oxidation
of ABTS (2,2=-azino-di-[3-ethylbenzthiazoline sulphonate]) to ABTS by
metmyoglobin. SOD activity was measured in erythrocytes using the Calbio-
chem assay kit (Novabiochem) based on the method developed by Nebot et al.
(16). Erythrocyte GPx activity was measured by using a GPx-340 assay kit
(Bioxytech, OXIS International, Portland, OR) as previously described by
Paglia and Valentine (17). Hb concentration was measured to obtain eryth-
rocyte SOD and glutathione concentration values in U/gHb.
Determination of lipid peroxidation parameters. Erythrocyte TBARS
content was measured according to Ohkawa et al. (18). TBARS concentra-
tions were expressed as nmol/gHb using 1,1,3,3-tetraethoxypropane as a
standard. Urine concentrations of F2-isoprostane (8-Epi-PGF2) were deter-
mined using an enzyme immunoassay kit based on the method developed by
Roberts and Morrow (19) (Bioxytech, OXIS International). Urinary content of
F2-isoprostane was indexed to creatinine and expressed as ng/mg of creati-
nine.
Statistical analysis. Categorical variables were compared using the 2 test.
Comparisons of continuous variables were performed using the F statistic.
Pearson’s coefficients and stepwise forward multiple linear regression analy-
ses of the overall cohort were used to investigate associations between
antioxidant or pro-oxidative parameters and other variables. Values of con-
tinuous variables were expressed as mean  SEM. Statistical tests were
two-tailed and the significance level was set at p  0.05.
RESULTS
Baseline characteristics. Clinical, anthropometric, and
metabolic characteristics of the children are shown in Table 1.
No difference was observed in the anthropometric evaluation,
and, with exception of the serum UA level, the groups did not
differ significantly with respect to the laboratory parameters.
The mean UA value was significantly greater in SGA com-
pared with AGA children [means difference: 1.2 mg/dL, 95%
confidence interval (CI): 0.8 to 1.6 mg/dL], and no race (p 
0.207) or gender (p  0.907) differences in UA levels were
observed in the entire cohort. Mean SBP was higher in SGA
than in AGA children (means difference: 8.9 mm Hg, 95% CI:
2.7 to 15.0 mm Hg), and mean diastolic BP levels were similar
in both groups. There were no significant race (p  0.291) or
Table 1. General and biochemical characteristics of the
population
Variables AGA n  27 SGA n  38 p
Gender (%) 0.573
Boys (%) 59 50
Girls (%) 41 50
Race 0.495
White (%) 44 34
Black (%) 56 66
Birth weight (g) 3171.9  32.8 2373.3  27.4 0.001
Gestational age (wk) 39.2  0.2 39.1  0.1 0.422
Age (y) 9.38  0.4 9.61  0.3 0.476
Weight (kg) 28.2  1.5 28.1  1.2 0.661
Height (cm) 133.6  2.4 133.9  1.8 0.672
WAZ -0.98 0.20 -0.99  0.15 0.926
HAZ -0.74 0.19 -0.76  0.15 0.862
BMIZ -0.97 0.23 -0.89  0.15 0.740
Cholesterol (mg/dL) 156.2 5.4 152.2.  4.9 0.938
LDL-c (mg/dL) 93.7 5.0 94.7  4.0 0.702
HDL-c (mg/dL) 51.0 2.5 53.3  2.3 0.486
Uric acid (mg/dL) 3.0  0.1 4.2  0.2 0.001
Mean systolic BP (mm Hg)* 98.5  2.6 107.4  2.0 0.001
Mean diastolic BP (mm Hg)* 63.6  2.4 68.2  2.0 0.122
Values expressed as means  SEM or percentage. LDL-c, low-density-
lipoprotein cholesterol; HDL-c, high-density-lipoprotein cholesterol.
* Average of two measurements made at 2-min intervals.
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gender (p  0.096) differences in the mean SBP levels in the
whole study group.
Evaluation of antioxidant activity. Our results showed that
erythrocyte GPx activity and plasma concentration of the TAS
did not differ between AGA and SGA children (Table 2). For
the entire cohort, no correlation was found between BW and
TAS (r  0.03, p  0.810) or GPx (r  0.04, p  0.720). On
the other hand, activity of the SOD enzyme was significantly
higher in the SGA than in the AGA group (means difference:
1012.6 U/g Hb, 95% CI: 584.3 to 1440.9 U/g Hb) (Table 2).
No significant race (p  0.968) or gender (p  0.481)
differences in the mean SOD levels in the whole study group
were observed. For the entire cohort, erythrocyte SOD activity
correlated significantly with BW (r  –0.453, p  0.001),
whereas adjustment for race, gender, age and BMIZ did not
significantly modify the strength of this association (r 
–0.375; p  0.003).
Evaluation of oxidative stress indices. Erythrocyte TBARS
and urinary F2-isoprostane levels were higher in SGA than in
AGA children (Table 2) (means difference: 70.9 nmol/g Hb,
95% CI: 29.1 to 112.7 nmol/g Hb; and 16.8 ng/mg creatinine,
95% CI: 6.3 to 27.3 ng/mg creatinine, respectively). No
statistical differences were found in gender (p 0.666) or race
(p  0.790) in the TBARS levels. However, we observed
significantly greater levels of F2-isoprostanes in black children
compared with white children (44.4  4.3 ng/mg creatinine
versus 27.8  2.9 ng/mg creatinine, respectively, p  0.009).
No difference was noted between males and females (p 
0.177) for this marker of lipid peroxidation. In addition, we
investigated the correlation between LPO and BW and ob-
served that levels of both TBARS (r  –0.342, p  0.003)
and F2-isoprostanes (r  –0.269, p  0.03) were inversely
correlated with BW. After controlling for gender and race,
these associations remained significant [TBARS (r  –0.302,
p  0.004) and F2-isoprostanes (r –0.251, p  0.050)].
Relationship between tbars, F2-isoprostanes, lipid profile,
and uric acid. A correlation was found between TBARS and
F2-isoprostanes (r 0.401, p 0.003). This was present after
adjusting for race, gender, and BW (r  0.376, p  0.006).
We also observed that serum cholesterol levels were posi-
tively associated with levels of both TBARS (r  0.658, p 
0.001) and F2-isoprostanes (r  0.265, p  0.038). Adjust-
ment for race, gender, BW, age, and BMIZ did not modify
these associations [TBARS (r  0.797, p  0.001) and
F2-isoprostanes (r  0.304, p  0.024)]. Erythrocyte TBARS
and LDL-c levels were significantly correlated (r  0.438,
p  0.001), whereas UA concentration was positively asso-
ciated only with F2-isoprostane levels (r  0.295, p  0.022).
Similar relationships were seen when we adjusted for race,
gender, BW, age, and BMIZ [TBARS (r  0.464, p  0.001)
and F2-isoprostanes (r  0.315, p  0.018)]. Subsequently, in
a multiple regression analysis testing BW, age, BMIZ and
blood lipids as independent variables, only cholesterol ( 
2.533; SE  0.226; p  0.001) and BW (  –0.075; SE 
0.015; p  0.001) showed significant associations with levels
of TBARS in our population. On the other hand, when the
dependent variable was F2-isoprostanes, only BW was a sig-
nificant predictor ( –0.0168; SE 0.006; p 0.010) even
after including age, BMIZ, UA, and blood lipids in the model.
Association between lipid peroxidation and systolic blood
pressure. We investigated the relationship between LPO and
systolic blood pressure. Controlling for gender and race we
found that TBARS correlated positively with systolic blood
pressure levels (r 0.243, p 0.040) for the entire cohort. In
contrast, F2-isoprostanes were not significantly correlated with
this clinical parameter (r  0.593, p  0.658). In a multiple
regression analysis, systolic blood pressure was significantly
associated with BW (  –0.0120; SE  0.003; p  0.001)
and gender (  8.609; SE  2.949; p  0.005), whereas
race, age, BMIZ, UA, blood lipids, and TBARS did not reach
statistical significance.
DISCUSSION
It has been proposed that events occurring before birth may
influence the risk of developing chronic cardiometabolic dis-
eases in later life, notably hypertension and diabetes (1–4).
Oxidative stress is a common feature of these pathogenic
conditions and can be the key link between prenatal growth
and increased morbidity later in life. This study was under-
taken to test the hypothesis that oxidative imbalances are
associated with birth weight in 8- to 13-y-old SGA children.
Our results revealed elevated concentrations of LPO end
products in blood and urine samples of SGA children, indi-
cating that oxidative stress is identified a decade after insults
during fetal life have occurred.
The body has developed a complex defense strategy to
minimize the damaging effects of various oxidants. Central to
this defense are the antioxidant enzymes of the blood, which
include SOD, GPx, and catalase. Previous studies demon-
strated that the activity of SOD, catalase, and glutathione were
lower in cord blood of the SGA newborn, indicating the
presence of a deficient antioxidant defense mechanism (7).
This does not appear to occur in children with SGA since we
observed that both GPx activity and TAS levels were un-
changed. This discrepancy might be due to differences in
efficiency of the antioxidant mechanisms existing in newborns
and children. The PO2 in utero has been found to range
between 11 and 60 mm Hg. These values correspond to
approximately 1–9% oxygen (compared with atmospheric
conditions of 21% oxygen), indicating that the earliest stages
Table 2. Oxidative stress markers in AGA and SGA children
AGA n  27 SGA n  38 p
Antioxidant defenses
Erythrocyte superoxide
dismutase activity (U/g Hb)
1737.2  121.6 2749.8  181.5 0.001
Erythrocyte glutathione
peroxidase activity (U/g Hb)
64.1  4.0 73.6  3.9 0.356
Plasma total antioxidant status
(mmol/L)
1.3  0.1 1.1  0.1 0.628
Pro-oxidants
Erythrocyte TBARS
(nmol/g Hb)
215.8  10.5 286.7  16.9 0.002
Urinary F2-isoprostanes
(ng/mg creatinine)
29.1  3.1 45.9  4.6 0.006
Values expressed as mean  SEM.
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of development take place under a low oxygen concentration
(20). Therefore, immediately after birth humans are exposed
to a higher oxygen pressure, promoting increased activation of
the antioxidative pathways. In fact, Asikainen et al. (21)
reported that expression of SOD mRNA in the lung and liver
are very low in fetuses and increases progressively toward
adulthood. Neonates have low antioxidant defenses in both
their extracellular and intracellular pathways (20). Thus, it is
possible that defense systems against free radicals in new-
borns are insufficient. On the other hand, we also found that
erythrocyte SOD activity is significantly elevated in SGA
children. Whatever the explanation for this current finding, it
suggests an important compensatory mechanism that protects
these children against the excess production of superoxide
radicals. In fact, this protective phenomenon can be observed
in some disorders characterized by the presence of oxidative
stress like type I and type II diabetes (22,23). However,
longitudinal studies are needed to confirm whether this adap-
tive mechanism observed in the current study really occurs in
SGA children.
LPO is a part of normal metabolism and its increased levels
are thought to be a consequence of oxidative stress. This is a
process whereby unsaturated fatty acids, phospholipids, gly-
colipids, cholesterol esters, and cholesterol itself are peroxi-
dized by free radical-mediated reactions and results in cell
damage (24). TBARS concentrations in erythrocytes represent
an index of free radical attack with potentially cytotoxic
consequences because oxidized lipids have wide-ranging ef-
fects on membrane function and cell metabolism (12). On the
other hand, isoprostanes are formed in the phospholipid do-
main of cell membranes; they reflect lipid peroxidation and
are excreted in the urine (11). In the current study, TBARS
and F2-isoprostanes showed an evident increase in SGA chil-
dren. For the entire cohort, we observed a positive association
between these oxidative biomarkers, suggesting that they are
responding to a common stimulus or are otherwise physiolog-
ically linked. Moreover, we also found a significant inverse
correlation between birth weight and both TBARS and F2-
isoprostanes in race- and sex-adjusted models. Other investi-
gators have noted the presence of LPO only among SGA
neonates or during adverse prenatal life (6–9) but not in SGA
children. It is unclear how fetal programming augments LPO
in children a decade later. From the present study, it is difficult
to infer the possible mechanisms involved in the oxidative
stress induced by fetal growth restriction. The “fetal program-
ming” hypothesis proposes that the fetus adapts to an adverse
intrauterine life to ensure survival, favoring the development
of some organs over that of others, thus promoting long-range
effects through childhood and into adult life (1,2). Moreover,
reprogramming of the redox state has been proposed as a key
adaptation enabling the fetus to survive in a limited nutrient
environment (25). Further studies are warranted to assess the
importance of this hypothesis and its subsequent correlation with
morbidity in later life and to elucidate the mechanisms involved
in this oxidative damage promoted by fetal programming.
Noteworthy were the data regarding the race-specific dif-
ferences in urinary isoprostanes concentration. The present
study revealed that isoprostane levels were significantly
higher in black children than in white children. The reason for
race-specific differences in urinary isoprostanes could not be
identified in this study, but some reports have demonstrated
that in acute hyperlipidemia, higher F2-isoprostane levels are
found in African Americans than in Caucasians (26). In
addition, higher levels of the polyunsaturated fat eicosapenta-
enoic acid are detected in patients of African origin than in
Caucasians, contributing to increases in lipid hydroperoxide
concentration (27). It was also reported that cultured endothe-
lial cells derived from African American patients release
greater quantities of superoxide and peroxynitrite radicals
compared with Caucasians, suggesting an inherent basis for
the racial differences in redox metabolism (28). Environmen-
tal factors, race differences in the distribution of genetic
polymorphisms, or both could contribute to differences ob-
served in isoprostane levels.
Lipid abnormalities and oxidative modification of LDL-c
may contribute to increased rates of LPO reactions (29). The
findings of our study support a direct relationship between
these variables since we found that total cholesterol levels
were positively correlated with both TBARS and F2-
isoprostanes. Moreover, we also observed significant associ-
ation between TBARS and LDL-c concentrations; adjustment
for BW, race, gender, age, and BMIZ did not modify the
strength of this association. The results of multiple regression
analysis indicate that BW and cholesterol were significantly
and independently related to TBARS in the combined study
population. These findings suggest that oxidative damage that
can be attributed to lipid peroxidation occurs to a greater
degree in the context of low birth weight.
Another surprising feature of this study was the positive
correlation between F2-isoprostanes and UA levels that was
observed in the entire cohort. An important consideration is
how the increase in UA levels should be converged with lipid
peroxidation. UA is known to act as an antioxidant and may be
one of the strongest determinants of plasma antioxidative
capacity (30). On the other hand, under determined pathologic
circumstances this antioxidant paradoxically becomes pro-
oxidant. This is demonstrated through its direct oxidation by
oxygen radicals, chemical oxidation with concomitant forma-
tion of allantoin, oxonic/oxaluric acid, and parabanic acid, and
urate anion free radical formation through a one-electron
redox process (30).
There is evidence that increased UA levels could have
pro-oxidant effects and hence promote lipid oxidation in vas-
cular tissue. It has been suggested that urate anion reacts with
a polyunsaturated fatty acid leading to the formation of a lipid
radical that, in the presence of molecular oxygen, would generate
a lipid peroxyl radical, thus propagating LPO within the LDL-c
particle (31). Although it is unknown whether circulating LDL-c
might represent a source of augmented urinary F2-isoprostanes,
studies have demonstrated that F2-isoprostanes is formed in
LDL-c when it is oxidized in vitro (31).
Finally, we found that systolic blood pressure was margin-
ally and positively associated with TBARS levels in race- and
gender-adjusted models, but not in a multivariable stepwise
model where BW as well as age emerged as significant
predictors of blood pressure. A number of experimental stud-
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ies have found strong positive association between a marker of
oxidative stress and hypertension. However, these relation-
ships may only apply to certain hypertensive states such as
those associated with high renin levels or salt sensitivity
(32,33). On the other hand, in human beings the determinants
of blood pressure are likely multifactorial, thus the specific
proportion of cases with oxidative stress–mediated hyperten-
sion may be too small to drive a significant association between
these variables.
The community-based sample and adjustment for socioeco-
nomic status and other confounders strengthen the findings of
our investigation. Potential limitations of our study include the
relatively small sample size of children studied and the pre-
dominant black race among SGA children that limit the
generalizability of our results to other populations.
In summary, the current study revealed that there is evi-
dence of oxidative stress in SGA children as evidenced by
increased lipid peroxidation. In contrast, increases in erythro-
cyte SOD activity was also seen in these children. Although
our study did not allow us to identify a mechanism for the
increased oxidative status found in children a decade after the
insult caused by adverse fetal life, these observations contrib-
ute to a better understanding of the link between birth weight
and later development of disease and has implications in
determining health risks in children.
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